kessingland pharma ltd Company Information
Company Number
14467019
Next Accounts
Aug 2025
Shareholders
jeremy key
mitul patel
View AllGroup Structure
View All
Industry
Dispensing chemist in specialised stores
Registered Address
205 plumstead road, norwich, NR1 4AB
Website
-kessingland pharma ltd Estimated Valuation
Pomanda estimates the enterprise value of KESSINGLAND PHARMA LTD at £539.1k based on a Turnover of £1.6m and 0.33x industry multiple (adjusted for size and gross margin).
kessingland pharma ltd Estimated Valuation
Pomanda estimates the enterprise value of KESSINGLAND PHARMA LTD at £281k based on an EBITDA of £71.3k and a 3.94x industry multiple (adjusted for size and gross margin).
kessingland pharma ltd Estimated Valuation
Pomanda estimates the enterprise value of KESSINGLAND PHARMA LTD at £111.7k based on Net Assets of £53.5k and 2.09x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Kessingland Pharma Ltd Overview
Kessingland Pharma Ltd is a live company located in norwich, NR1 4AB with a Companies House number of 14467019. It operates in the dispensing chemist in specialised stores sector, SIC Code 47730. Founded in November 2022, it's largest shareholder is jeremy key with a 33.3% stake. Kessingland Pharma Ltd is a startup, small sized company, Pomanda has estimated its turnover at £1.6m with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Kessingland Pharma Ltd Health Check
Pomanda's financial health check has awarded Kessingland Pharma Ltd a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 4 areas for improvement. Company Health Check FAQs


3 Strong

2 Regular

4 Weak

Size
annual sales of £1.6m, make it smaller than the average company (£12.3m)
- Kessingland Pharma Ltd
£12.3m - Industry AVG

Growth
There is insufficient data available for this Key Performance Indicator!
- Kessingland Pharma Ltd
- - Industry AVG

Production
with a gross margin of 26.6%, this company has a comparable cost of product (32%)
- Kessingland Pharma Ltd
32% - Industry AVG

Profitability
an operating margin of 4.4% make it more profitable than the average company (2.9%)
- Kessingland Pharma Ltd
2.9% - Industry AVG

Employees
with 8 employees, this is below the industry average (75)
8 - Kessingland Pharma Ltd
75 - Industry AVG

Pay Structure
on an average salary of £26.2k, the company has an equivalent pay structure (£26.2k)
- Kessingland Pharma Ltd
£26.2k - Industry AVG

Efficiency
resulting in sales per employee of £203.5k, this is more efficient (£143.7k)
- Kessingland Pharma Ltd
£143.7k - Industry AVG

Debtor Days
it gets paid by customers after 59 days, this is later than average (30 days)
- Kessingland Pharma Ltd
30 days - Industry AVG

Creditor Days
its suppliers are paid after 139 days, this is slower than average (64 days)
- Kessingland Pharma Ltd
64 days - Industry AVG

Stock Days
There is insufficient data available for this Key Performance Indicator!
- Kessingland Pharma Ltd
- - Industry AVG

Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Kessingland Pharma Ltd
- - Industry AVG

Debt Level
it has a ratio of liabilities to total assets of 96.4%, this is a higher level of debt than the average (59.3%)
96.4% - Kessingland Pharma Ltd
59.3% - Industry AVG
KESSINGLAND PHARMA LTD financials

Kessingland Pharma Ltd's latest turnover from November 2023 is estimated at £1.6 million and the company has net assets of £53.5 thousand. According to their latest financial statements, Kessingland Pharma Ltd has 8 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Nov 2023 | |
---|---|
Turnover | |
Other Income Or Grants | |
Cost Of Sales | |
Gross Profit | |
Admin Expenses | |
Operating Profit | |
Interest Payable | |
Interest Receivable | |
Pre-Tax Profit | |
Tax | |
Profit After Tax | |
Dividends Paid | |
Retained Profit | |
Employee Costs | |
Number Of Employees | 8 |
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Nov 2023 | |
---|---|
Tangible Assets | 1,202,147 |
Intangible Assets | |
Investments & Other | |
Debtors (Due After 1 year) | |
Total Fixed Assets | 1,202,147 |
Stock & work in progress | |
Trade Debtors | 266,093 |
Group Debtors | |
Misc Debtors | |
Cash | |
misc current assets | |
total current assets | 266,093 |
total assets | 1,468,240 |
Bank overdraft | |
Bank loan | |
Trade Creditors | 456,624 |
Group/Directors Accounts | |
other short term finances | |
hp & lease commitments | |
other current liabilities | |
total current liabilities | 456,624 |
loans | |
hp & lease commitments | |
Accruals and Deferred Income | |
other liabilities | 958,139 |
provisions | |
total long term liabilities | 958,139 |
total liabilities | 1,414,763 |
net assets | 53,477 |
total shareholders funds | 53,477 |
Nov 2023 | |
---|---|
Operating Activities | |
Operating Profit | |
Depreciation | |
Amortisation | |
Tax | |
Stock | |
Debtors | 266,093 |
Creditors | 456,624 |
Accruals and Deferred Income | |
Deferred Taxes & Provisions | |
Cash flow from operations | |
Investing Activities | |
capital expenditure | |
Change in Investments | |
cash flow from investments | |
Financing Activities | |
Bank loans | |
Group/Directors Accounts | |
Other Short Term Loans | |
Long term loans | |
Hire Purchase and Lease Commitments | |
other long term liabilities | 958,139 |
share issue | |
interest | |
cash flow from financing | |
cash and cash equivalents | |
cash | |
overdraft | |
change in cash |
kessingland pharma ltd Credit Report and Business Information
Kessingland Pharma Ltd Competitor Analysis

Perform a competitor analysis for kessingland pharma ltd by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other small companies, companies in NR1 area or any other competitors across 12 key performance metrics.
kessingland pharma ltd Ownership
KESSINGLAND PHARMA LTD group structure
Kessingland Pharma Ltd has no subsidiary companies.
Ultimate parent company
KESSINGLAND PHARMA LTD
14467019
kessingland pharma ltd directors
Kessingland Pharma Ltd currently has 2 directors. The longest serving directors include Mr Jeremy Key (Nov 2022) and Mr Kanwardeep Dhanoa (Nov 2023).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Jeremy Key | England | 38 years | Nov 2022 | - | Director |
Mr Kanwardeep Dhanoa | England | 47 years | Nov 2023 | - | Director |
P&L
November 2023turnover
1.6m
0%
operating profit
71.3k
0%
gross margin
26.7%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
November 2023net assets
53.5k
0%
total assets
1.5m
0%
cash
0
0%
net assets
Total assets minus all liabilities
Similar Companies
kessingland pharma ltd company details
company number
14467019
Type
Private limited with Share Capital
industry
47730 - Dispensing chemist in specialised stores
incorporation date
November 2022
age
3
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
November 2023
previous names
N/A
accountant
-
auditor
-
address
205 plumstead road, norwich, NR1 4AB
Bank
-
Legal Advisor
-
kessingland pharma ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 2 charges/mortgages relating to kessingland pharma ltd. Currently there are 2 open charges and 0 have been satisfied in the past.
kessingland pharma ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for KESSINGLAND PHARMA LTD. This can take several minutes, an email will notify you when this has completed.
kessingland pharma ltd Companies House Filings - See Documents
date | description | view/download |
---|